Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kintara Therapeutics, Inc.

Clinical trials sponsored by Kintara Therapeutics, Inc., explained in plain language.

Now part of TuHURA Biosciences, Inc. HURA NASDAQ

A clinical-stage biopharmaceutical company developing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New combo therapy targets tough brain tumors

Disease control Completed

This phase 2 trial tested a drug called VAL-083 combined with standard radiation in 29 people with newly diagnosed glioblastoma, a fast-growing brain cancer. The study focused on patients whose tumors have a specific genetic marker (unmethylated MGMT) that makes them resistant to…

Phase: PHASE2 • Sponsor: Kintara Therapeutics, Inc. • Aim: Disease control

Last updated Jun 26, 2026 14:06 UTC